Order Article Reprints

Kraus F, El Hajj H, Le Deley M-C, Aissaoui O, Gachon B, Chevalier A, Abdeddaim C, Lemaire A-S, Ben Haj Amor M, Sylla D, et al. A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction. Cancers. 2021; 13(19):4925. https://doi.org/10.3390/cancers13194925

Kraus, Francois, Houssein El Hajj, Marie-Cécile Le Deley, Othman Aissaoui, Bertrand Gachon, Annick Chevalier, Cyril Abdeddaim, Anne-Sophie Lemaire, Mariem Ben Haj Amor, Dienabou Sylla, and et al. 2021. "A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction" Cancers 13, no. 19: 4925. https://doi.org/10.3390/cancers13194925

Kraus, F., El Hajj, H., Le Deley, M.-C., Aissaoui, O., Gachon, B., Chevalier, A., Abdeddaim, C., Lemaire, A.-S., Ben Haj Amor, M., Sylla, D., Leblanc, E., Narducci, F., & Hudry, D. (2021). A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction. Cancers, 13(19), 4925. https://doi.org/10.3390/cancers13194925